Fumihiko Akahoshi

This inventor holds 10 USPTO granted patents, plus 1 CIPO patent and 6 EPO patents. Top assignees: Mitsubishi Tanabe Pharma Corporation, Mitsubishi Pharma Corporation. Active years: 2006-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumihiko Akahoshi. Retrieved from https://idiyas.com/inventor/fumihiko-akahoshi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 50.0

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 1)

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 223(Granted Patents)

Location History:

Tokyo, JP (2006 - 2013)
Osaka, JP (2014 - 2020)

Company Filing History:

8 out of 263

Mitsubishi Tanabe Pharma Corporation

patents

2 out of 73

Mitsubishi Pharma Corporation

patents

Years Active: 2006-2020

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10717731 - Nitrogen-containing aromatic heterocyclic compound (2020-07-21),

2. 10329263 - Disubstituted 1, 2, 4-triazine compound (2019-06-25),

3. 10029993 - Disubstituted 1, 2, 4-triazine compound (2018-07-24),

4. 8754032 - Concomitant pharmaceutical agents and use thereof (2014-06-17),

5. 8604198 - Salt of proline derivative, solvate thereof, and production method thereof (2013-12-10),

6. 8003790 - Salt of proline derivative, solvate thereof, and production method thereof (2011-08-23),

7. 7790725 - Thiazolidine derivatives and medicinal use thereof (2010-09-07),

8. 7504423 - α-amino acid derivatives and use thereof as medicines (2009-03-17),

9. 7074794 - Proline derivatives and the use thereof as drugs (2006-07-11),

10. 7060722 - Proline derivatives and use thereof as drugs (2006-06-13),

Title: Fumihiko Akahoshi: Innovator in Pharmaceutical Chemistry

Introduction

Fumihiko Akahoshi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit aldosterone synthetase. With a total of 10 patents to his name, Akahoshi's work has the potential to impact various therapeutic areas.

Latest Patents

Among his latest patents is a nitrogen-containing aromatic heterocyclic compound. This compound is represented by a general formula wherein specific groups are defined, and it has demonstrated inhibitory activity on aldosterone synthetase. This makes it useful as a prophylactic and therapeutic agent for diseases associated with aldosterone. Another notable patent is for a disubstituted 1,2,4-triazine compound, which also exhibits aldosterone synthetase inhibitory activity. This invention includes a method for preparation and a pharmaceutical composition that incorporates this compound as an active ingredient.

Career Highlights

Fumihiko Akahoshi has worked with notable companies in the pharmaceutical industry, including Mitsubishi Tanabe Pharma Corporation and Mitsubishi Pharma Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.

Collaborations

Throughout his career, Akahoshi has collaborated with esteemed colleagues such as Hiroshi Sakashita and Yoshiharu Hayashi. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Fumihiko Akahoshi's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work continues to pave the way for new therapeutic options in the treatment of diseases related to aldosterone.

Profile summary based on public USPTO records.